Posted by Michael Wonder on 20 Jan 2026
New iron treatment proposed for people who have experienced low phosphate levels
20 January 2026 - PHARMAC is asking for feedback on a proposal to fund a new iron treatment, ferric derisomaltose (Monofer), in hospitals from 1 March 2026.
Ferric derisomaltose (Monofer) is an iron infusion given through an intravenous drip. It is used for people with low iron levels who have experienced low phosphate levels (hypophosphataemia) after other iron infusions.
